Pioneering bacterial therapy for the skin. | Pioneering bacterial therapy for the skin
36 Patients
2 Week Phase 2
372 Patients
12 Week Phase 3
36 Subjects (R/L)
4 Week Cosmetic
20 Subjects (R/L)
4 Week Cosmetic
30 Subjects
4 Week
AOBiome Therapeutic Pipeline
Skin Conditions
Acne
(Science37)
Keratosis
Pilaris
(SkinCare Physicians)
Adult Eczema
Allergic Rhinitis
Pediatric
Atopic Dematitis
100 Patients
6 Week Ph 2
Rosacea
82 Patients
12 Wk Ph 2
Welcome to AOBiome.
AOBiome is dedicated to advancing the science of AOB on human health. The human microbiome when subjected to modern hygienic routines selectively depletes potentially important Ammonia Oxidizing Bacteria (AOB).

Topical applications of patented and stabilized Ammonia Oxidizing Bacteria can restore the skin's microbiome and potentially impact a wide variety of human health conditions.

We conduct primary research, collaborate with others on research and develop applications to positively impact skin conditions,reduce inflammation and risk of infection.